Belfast Telegraph

Friday 22 August 2014

Glaxo chiefs 'confess to bribery'

A woman enters an office of GlaxoSimthKline in Beijing. China's police ministry has accused executives of conducting a large and long-running bribery campaign (AP)

Executives of pharmaceutical supplier GlaxoSmithKline have been accused by Chinese officials of conducting a large, long-running bribery campaign to persuade doctors to prescribe drugs.

GSK employees are accused of paying "large bribes" laundered through travel agencies to doctors, hospitals and others to "to open new sales channels and increase drug revenues," said a Public Security Ministry announcement. It said the scheme "lasted a long time" but gave no details.

They also are suspected of tax offences involving collusion with travel agencies to issue false invoices, the ministry said. It identified the employees only as "high officials" of Britain-based GSK and gave no details of the size of payments or who received them. "After questioning, the suspects confessed to the crime," the statement said.

GSK said it would co-operate with the authorities but said Thursday's announcement was the first official communication it has received about the investigation.

"Corruption has no place in our business," said a company statement. "If evidence of such activity is provided we would of course act swiftly on it."

A police ministry press office spokeswoman said she could not release the GSK employees' names or other details because they have not been charged with a crime.

Police in the central city of Changsha announced two weeks ago that GSK employees had been detained for questioning about unspecified "economic crimes." Thursday's statement said the investigation also took place in Shanghai and the central city of Zhengzhou.

GlaxoSmithKline said in June that it had investigated an accusation that its salespeople in China bribed doctors and found no evidence of wrongdoing. The company has said the police investigation might be based on information from the same anonymous source.

GlaxoSmithKline PLC is headquartered in Britain but has a presence in the United States, which could make it liable to penalties under US anti-bribery laws.

Last week, state media reported the government was investigating production costs for 60 foreign and domestic drug companies in a possible first step toward changing state-set maximum prices. The announcement gave no indication any companies were suspected of wrongdoing.

COMMENT RULES: Comments that are judged to be defamatory, abusive or in bad taste are not acceptable and contributors who consistently fall below certain criteria will be permanently blacklisted. The moderator will not enter into debate with individual contributors and the moderator’s decision is final. It is Belfast Telegraph policy to close comments on court cases, tribunals and active legal investigations. We may also close comments on articles which are being targeted for abuse. Problems with commenting? customercare@belfasttelegraph.co.uk

Latest News

Latest Sport

Latest Showbiz